Skip to main content

Table 2 Final diagnoses

From: Abdominal fat pad biopsies exhibit good diagnostic accuracy in patients with suspected transthyretin amyloidosis

 

Male (n = 167)

Female (n = 107)

All (n = 274)

No amyloidosis

80 (48%)

62 (58%)

142 (52%)

 TTR mutation

22 (28%)

31 (50%)

53 (37%)

 No TTR mutation

58 (72%)

31 (50%)

89 (63%)

Amyloidosis

87 (52%)

45 (42%)

132 (48%)

 ATTRv amyloidosis

82 (94%)

41 (91%)

123 (93%)

 Dx before 2006

10 (12%)

9 (22%)

19 (16%)

 ATTRV30M

69 (84%)

31 (76%)

100 (81%)

 Other mutationa

3 (4%)

1 (2%)

4 (3%)

 ATTRwt amyloidosis

1 (1%)

0 (0%)

1 (1%)

 AL amyloidosis

4 (5%)

3 (7%)

7 (5%)

 Localized

3 (75%)

3 (100%)

6 (86%)

 Systemic

1 (25%)

0 (0%)

1 (14%)

 Gelsolin amyloidosis

0 (0%)

1 (2%)

1 (1%)

  1. aH88R, A45S, V122I and A97S; AL, amyloid light chain; ATTRv, variant transthyretin amyloidosis; ATTRV30M, transthyretin amyloidosis caused by the TTR V30M mutation; ATTRwt, wild-type transthyretin amyloidosis; Dx, diagnosis; TTR, transthyretin gene. Percentages are shown as column percentage within each heading/subheading